Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma

This study has been completed.
Information provided by:
Memorial Sloan Kettering Cancer Center Identifier:
First received: January 12, 2007
Last updated: February 25, 2010
Last verified: February 2010
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2010
  Primary Completion Date: February 2010 (Final data collection date for primary outcome measure)